AF and AFL incident cases rose in all BRICS by 2021, driven mainly by population growth; India had 570,120 cases, China 916,180, with varied ASIR trends forecasted to 2036.
Demographic forces, particularly population growth, are key drivers of the increasing burden of atrial fibrillation and flutter across BRICS nations, necessitating tailored healthcare resource allocation.
Absolute Event Rate: 0% vs 0%
Atrial fibrillation (AF) and atrial flutter (AFL) are major and rising causes of cardiovascular morbidity, but comparable long-term evidence across Brazil, Russia, India, China, South Africa (BRICS) is limited. We conducted a population level, retrospective ecological time-trend analysis using aggregated Global Burden of Disease 2021 estimates (1992–2021). We analyzed incident cases and age-standardized incidence rates (ASIRs). Age-period-cohort models quantified age, period, and cohort effects; decomposition assessed drivers of case growth; and autoregressive integrated moving average projected ASIRs for 2022 to 2036. Incident cases increased in all BRICS countries, with the highest 2021 counts in China (9,16,180) and India (5,70,120). ASIR trends differed: Brazil declined to 2019 with a recent uptick; China was relatively stable (44.9 per 1,00,000 in 2021); Russia peaked in the early 2010s then declined; India rose slightly; and South Africa declined modestly. Population growth was a major driver (India 74.71%; China 55.69%; South Africa 96.96%). By 2036, ASIRs are projected to remain high in Brazil (67.63), increase in Russia (57.22), and decline then stabilize in China (42.47); India will slightly decrease (50.07) and South Africa will remain stable (48.66). The findings highlight demographic forces as key determinants of AF/AFL burden and imply the need for tailored screening, prevention, and surveillance to guide allocation of cardiovascular care resources across BRICS.
Gao et al. (Fri,) reported a other. AF and AFL incident cases rose in all BRICS by 2021, driven mainly by population growth; India had 570,120 cases, China 916,180, with varied ASIR trends forecasted to 2036.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: